MIGUEL JOSÉ
MARTÍN JIMÉNEZ
Catedrático de universidad
University of Texas Health Science Center at San Antonio
San Antonio, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von University of Texas Health Science Center at San Antonio (1)
2022
-
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
Journal for immunotherapy of cancer, Vol. 10, Núm. 2